Come up with a name for your new list and we'll add to it:
Organogenesis raised a round of funding on May 22, 2017. Investors include
Eastward Capital Partners.
Organogenesis provides advanced wound care products for bio-active wound healing and soft tissue regeneration. The portfolio includes FDA-approved Apligraf and Dermagraft, for bio-active wound healing…